SMTI

Sanara Medtech Inc

17.29

+0.33+1.95%

Closed16:10 03/30 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE16.99/16.96

TODAY RANGE16.60-17.82

VOL65.59K

MARKET CAP158.50M

52 WEEK RANGE16.05-35.95

AVG VOL (3M)68.03K

% TURNOVER0.72%

TURNOVER0

P/E (TTM)-3.9691

% RANGE7.16%

EPS(TTM)-4.3561

P/E(FORWARD)26.60

P/B26.05

BVPS0.6637

DIVIDEND--

P/S1.500

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP52.92M

SHARES OUTSTANDING9.17M

NEXT EARNINGS05/12-05/18

FREE FLOAT3.06M

LOT SIZE1

EX-DATE05/10/2019

News

Press Releases

Financial Reports

Profile

TipRanks·3d ago
Sanara MedTech Earnings Call Signals Growth Momentum
Seeking Alpha·6d ago
Sanara MedTech outlines 2026 net revenue guidance of $116M–$121M while expanding distributor network and product reach
Seeking Alpha·03/24 11:19
Sanara MedTech GAAP EPS of -$0.19, revenue of $27.5M
Reuters·03/24 11:08
Sanara MedTech posts higher Q4 revenue, reaffirms guidance
Reuters·03/24 11:03
Sanara Q4 net loss from continuing operations hits USD 1 million as adjusted EBITDA rises 16% to USD 5 million
Dow Jones·03/24 11:02
*Sanara MedTech Backs FY26 Rev $116M-$121M >SMTI
Dow Jones·03/24 11:02
*Sanara MedTech Backs Full-Year Net Revenue Growth 13%-17%
Dow Jones·03/24 11:01
*Sanara MedTech 4Q Rev $27.5M >SMTI
Dow Jones·03/24 11:01
*Sanara MedTech 4Q Loss/Shr 19c >SMTI
Reuters·03/24 11:00
SANARA MEDTECH INC. REPORTS FOURTH QUARTER (UNAUDITED) AND FULL YEAR 2025 FINANCIAL RESULTS; REAFFIRMED FULL YEAR 2026 FINANCIAL GUIDANCE
Reuters·03/24 11:00
SANARA MEDTECH INC - REAFFIRMS FY2026 NET REVENUE GUIDANCE $116-$121 MLN, GROWTH OF 13%-17%
Reuters·03/24 11:00
SANARA MEDTECH FY REVENUE USD 103.1 MILLION
NASDAQ·03/23 20:00
Pre-Market Earnings Report for March 24, 2026 : SFD, CNM, CNXC, LENZ, EVTL, ACHV, FENC, SMTI, NRXP
TipRanks·03/11 11:35
Sanara MedTech announces publication of study on CellerateRX Surgical Powder
Reuters·03/11 11:31
Sanara MedTech study reports USD 3,852 per-patient savings with CellerateRX in high-risk spine surgery wounds

Same Industry

Name/Symbol

Change%

Price

SMTI

MCK

BIIB

Amgen Inc

AMGN

-1.24%

348.77

SHPG

CELG-RT

Lilly Eli & Co

LLY

+0.96%

886.63

CELG

TXMD

Johnson & Johnson

JNJ

+0.51%

240.45

Abbvie Inc

ABBV

-0.81%

209.40

Zoetis Inc

ZTS

-2.81%

113.35

Gilead Sciences Inc

GILD

+1.56%

136.34

NVO

BMY

ALXN

Pfizer

PFE

-1.92%

27.04

Sanofi FR

SNY

-0.13%

46.72

GCVRZ

Novartis

NVS

-1.02%

148.18

RDY

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.